ALNY - Alnylam Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ALNY is currently covered by 23 analysts with an average price target of $426.16. This is a potential upside of $193.48 (83.15%) from yesterday's end of day stock price of $232.68.

Alnylam Pharmaceuticals's activity chart (see below) currently has 727 price targets and 602 ratings on display. The stock rating distribution of ALNY is 80.77% BUY and 19.23% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 82.56% with an average time for these price targets to be met of 224.32 days.

Highest price target for ALNY is $549, Lowest price target is $256, average price target is $426.16.

Most recent stock forecast was given by LUCA ISSI from RBC.

Best performing analysts who are covering ALNY - Alnylam Pharmaceuticals:

Patrick Trucchio Whitney Ijem Madhu Kumar Edward Tenthoff David Lebowitz

Currently out of the existing stock ratings of ALNY, 63 are a BUY (80.77%), 15 are a HOLD (19.23%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 20-Sep-2022

$345

$112.32 (48.27%)

$350

Buy Since 15-May-2025

$369

$136.32 (58.59%)

$375

12 days ago
(30-Sep-2026)

9/12 (75%)

$122.26 (49.55%)

30

Buy Since 12-Feb-2021

$455

$222.32 (95.55%)

$455

21 days ago
(21-Sep-2026)

24/43 (55.81%)

$210.68 (86.23%)

682

Hold Since 31-Mar-2026

$260

$27.32 (11.74%)

$330

1 months 4 days ago
(08-Sep-2026)

3/3 (100%)

$-0.1 (-0.04%)

6

Buy Since 21-Mar-2025

$318

$85.32 (36.67%)

$583

1 months 23 days ago
(19-Aug-2026)

34/36 (94.44%)

$75.39 (31.07%)

273

Show more analysts

Please expand the browser size to see the chart

What is ALNY (Alnylam Pharmaceuticals) average time for price targets to be met?

On average it took 224 days for the stock forecasts to be reached, with an average price target met ratio of 82.56%.

Which analyst most recently updated their price target on ALNY (Alnylam Pharmaceuticals)?

Luca Issi

Which analyst has the most public recommendations on ALNY (Alnylam Pharmaceuticals)?

Luca Issi works at RBC and has 7 price targets and 10 ratings on ALNY

Which analyst is the currently most bullish on ALNY (Alnylam Pharmaceuticals)?

Salveen Richter with the highest potential upside of $333.32

Which analyst is the currently most reserved on ALNY (Alnylam Pharmaceuticals)?

Christopher Marai with the lowest potential downside of -$145.72
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?